Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...

Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping ...

TAKEAWAYS FROM THE HEALTH CARE DEAL — Pharmacy benefit managers may soon have to comply with new regulations under an ...

The dengue viruses primarily circulate in the tropics and subtropics and are transmitted to people by infected mosquitoes.

Sanofi and Teva Pharmaceuticals have reported that the Phase IIb RELIEVE UCCD study of the human IgG1-λ2 monoclonal antibody ...

It's a special delivery for Pocono Services for Families and Children at the Mountain Center in Tobyhanna. Bag after bag of ...

Sanofi (SNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

As India's cleanest city, Indore is on a mission to become beggar-free by January 1, 2025. Discover the truth behind this ...

Sanofi & Teva Pharma’s RELIEVE UCCD phase 2b study of duvakitug in ulcerative colitis and Crohn’s disease meets primary endpoints: Paris Thursday, December 19, 2024, 11:00 Hrs ...

Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks David Risinger has given his Buy rating due to a combination of factors that highlight the promising potential of ...

Merck signed a deal worth up to $2 billion with Hansoh Pharma to develop and sell the Chinese biotech's oral obesity drug ...